Medicalcv (MM) (NASDAQ:MDCV)
Historical Stock Chart
From Jun 2019 to Jun 2024
![Click Here for more Medicalcv (MM) Charts. Click Here for more Medicalcv (MM) Charts.](/p.php?pid=staticchart&s=N%5EMDCV&p=8&t=15)
MedicalCV to Present at Medtech Insight's 'Investment in
Innovation' Conference
Company Scheduled to Present in San Francisco on Tuesday, June 14, 2005
MINNEAPOLIS, June 14 /PRNewswire-FirstCall/ -- MedicalCV, Inc. (OTC:MDCV)
(BULLETIN BOARD: MDCV) , http://www.medcvinc.com/ , a cardiovascular surgery
device manufacturer, announced that it will be presenting today, Tuesday, June
14, 2005 at 3:35 p.m., at Medtech Insight's "Investment In Innovation (In3): A
Preview of Early-Stage Medical Technology Companies" Conference, taking place
June 14-15, 2005 at The Palace Hotel in San Francisco, CA.
Marc P. Flores, president and chief executive officer of MedicalCV Inc. will be
presenting and will discuss the Company's technologies and applications for the
treatment of atrial fibrillation; clinical references; and marketing strategy.
This two-day event will highlight emerging medical technology companies. The
meeting is expected to draw an attendance of over 400 senior executives from
the investment community and major medical technology, biopharmaceutical,
biotech, and other companies.
"We are honored to have this opportunity to present our story of repositioning,
redirecting and growing MedicalCV into the atrial fibrillation market. This
conference allows us to meet with members of the financial community and
potential business partners," commented Mr. Marc Flores.
Management will be available to meet with interested parties and the media to
answer questions. To schedule a meeting, please contact Traci Christensen at
headquarters, phone (651) 452-3000 or via email at .
Medtech Insight, a division of Windhover Information Inc., is a leading
provider of business information and market intelligence for the medical
technology marketplace. To register for the "Investment In Innovation"
conference or for more information on Medtech Insight, please call Kristy
Grimes at 480-985-9512, e-mail , or visit http://www.medtechinsight.com/ .
About MedicalCV, Inc.
MedicalCV, Inc., a cardiovascular surgery device manufacturer, focuses on the
development and introduction of products designed to improve patient outcomes
through the early treatment of cardiovascular disorders and disease,
specifically products used by cardiac surgeons to ablate cardiac tissue as a
potential means to treat atrial fibrillation. The Company's core technology is
the ATRILAZE Surgical Ablation System for use in cardiac tissue ablation
procedures in open-heart surgery. The Company acquired this technology in
August 2003 and received its FDA 510(k) clearance in November 2004. The
ATRILAZE(TM) system is being utilized for concomitant open-heart surgical
procedures. The Company's common stock is traded on the OTC Bulletin Board
under the symbol "MDCV."
For further information on MedicalCV, Inc., please visit
http://www.medcvinc.com/ .
You may register to receive MedicalCV's future press releases and to be added
to the Company's distribution list by visiting: http://www.roiny.com/form.php .
MedicalCV, Inc. Contact: Investor Relations Contact:
John H. Jungbauer ROI Group Associates, Inc.
Vice President, Finance & CFO Robert Giordano / Sarah Shepard
Phone 651.452.3000 President / Vice President
Phone 212.495.0200, ext. 10 / 17
http://www.medcvinc.com/ /
http://www.roiny.com/
DATASOURCE: MedicalCV, Inc.
CONTACT: John H. Jungbauer, Vice President, Finance & CFO of MedicalCV,
Inc., +1-651-452-3000, , or Investor Relations, Robert
Giordano, President, +1-212-495-0200, ext. 10, , or Sarah
Shepard, Vice President, +1-212-495-0200, ext. 17, , both
of ROI Group Associates, Inc.
Web site: http://www.medcvinc.com/
http://www.medtechinsight.com/
http://www.roiny.com/form.php